IFI16 promotes the progression of clear cell renal cell carcinoma through the IL6/PI3K/AKT axis

• Published in: Journal of translational medicine 2024-06, Vol.22 (1), p.533-533
• Main Authors: Lu, Ke, Zhao, Yan, Li, Yu, Fu, Zhenyu, Chen, Yongchang, Kong, Ying, Li, Gang
• Format: Article
• Language: English
• Subjects: Animals; Biological response modifiers; Carcinoma, Renal cell; Carcinoma, Renal Cell - genetics; Carcinoma, Renal Cell - metabolism; Carcinoma, Renal Cell - pathology; Cell Line, Tumor; Cell Movement - genetics; Cell Proliferation; Clear cell renal cell carcinoma; Development and progression; Disease Progression; EMT; Epithelial-Mesenchymal Transition - genetics; Female; Gene Expression Regulation, Neoplastic; Health aspects; Humans; IFI16; Interferon; Interleukin-6; Interleukin-6 - metabolism; Kidney Neoplasms - genetics; Kidney Neoplasms - metabolism; Kidney Neoplasms - pathology; Male; Metastasis; Mice, Nude; Neomycin; Neoplasm Invasiveness; Nuclear Proteins - genetics; Nuclear Proteins - metabolism; Phosphatidylinositol 3-Kinases - metabolism; Phosphoproteins - genetics; Phosphoproteins - metabolism; PI3K/AKT; Prognosis; Proto-Oncogene Proteins c-akt - metabolism; Signal Transduction; Stem cells; Tumor progression
• ISSN: 1479-5876; 1479-5876
• DOI: 10.1186/s12967-024-05354-w

Clear cell renal cell carcinoma (ccRCC) is a common disease in the urinary system, with a high incidence and poor prognosis in advanced stages. Although γ-interferon-inducible protein 16 (IFI16) has been reported to play a role in various tumors, its involvement in ccRCC remains poorly documented, and the molecular mechanisms are not yet clear. We conducted bioinformatics analysis to study the expression of IFI16 in ccRCC using public databases. Additionally, we analyzed and validated clinical specimens that we collected. Subsequently, we explored the impact of IFI16 on ccRCC cell proliferation, migration, and invasion through in vitro and in vivo experiments. Furthermore, we predicted downstream molecules and pathways using transcriptome analysis and confirmed them through follow-up experimental validation. IFI16 was significantly upregulated in ccRCC tissue and correlated with poor patient prognosis. In vitro, IFI16 promoted ccRCC cell proliferation, migration, and invasion, while in vivo, it facilitated subcutaneous tumor growth and the formation of lung metastatic foci. Knocking down IFI16 suppressed its oncogenic function. At the molecular level, IFI16 promoted the transcription and translation of IL6, subsequently activating the PI3K/AKT signaling pathway and inducing epithelial-mesenchymal transition (EMT). IFI16 induced EMT through the IL6/PI3K/AKT axis, promoting the progression of ccRCC.